College of Animal Sciences and Technology, Guangxi University, Nanning, China.
Pharmacol Res. 2021 Aug;170:105694. doi: 10.1016/j.phrs.2021.105694. Epub 2021 Jun 2.
As an effective drug against acute enteritis diarrhea, Gegen Qinlian decoction (GQD) has a history of 2000 years. However, the potential molecular mechanism through which GQD could protect intestinal barrier from ulcerative colitis (UC) still remains undefined. As an important part of the homeostasis of the colon, gut microbiota is closely related to the dynamic evolution of the surrounding environment and the adjustment of dietary structure. At present, the effectiveness and mechanism of Jiawei Gegen Qinlian decoction against UC in different dietary environments are not clear. Here, the main active components of Jiawei Gegen Qinlian Decoction (PBM), were selected to construct a reasonable and effective compound scheme. We adopted "5% dextran sulfate sodium (DSS)" and "high temperature and humidity + high sugar and high fat + alcohol + 5%DSS" to induce UC rat models in general environment and UC rat models in Lingnan area, respectively. Then, we examined the therapeutic effects of PBM (89.96 mg/kg and 179.92 mg/kg) on two kinds of UC rats. The role of gut microbiota in the anti-UC effect of PBM was identified by intestinal flora consumption and fecal microbiota transplantation (FMT) experiments. Subsequently, we monitored the alterations of gut microbiota and fecal metabolism in the rat colon by 16Sr DNA technique and targeted metabonomics, respectively. The colon inflammation of the PBM-treated and the FMT-treated rats both showed significant relief, as evidenced by a reduction in body weight loss, bloody stool, diarrhea, disease activity index (DAI) score, shortening of colon length as well as decreased colon histology damage. Interestingly enough, the depletion of intestinal flora took away the protective effect of PBM, confirming the importance of intestinal flora in the anti-UC effect of PBM. Then our findings suggested that PBM could not only regulate the gut microbiota by increasing Akkermansia and Romboutsia but also decrease Escherichia-Shigella. More importantly, PBM could increase the production of propionate and total short-chain fatty acids (SCFAs) in colitis rats, regulate medium and long chain fatty acids (M-LCFAs), maintain bile acids (BAs) homeostasis, and regulate amino acids (AAs) metabolism. The transformation of intestinal environment might be related to the upregulation of anti-inflammation, anti-oxidation and tight junction protein expression in colonic mucosa. In summary, PBM showed potential for anti-UC activity through gut microbiota dependence and was expected to be a complementary and alternative medicine herb therapy.
作为一种治疗急性肠炎腹泻的有效药物,葛根芩连汤(GQD)已有 2000 年的历史。然而,GQD 保护肠道屏障免受溃疡性结肠炎(UC)的潜在分子机制仍未确定。肠道微生物群作为结肠内稳态的重要组成部分,与周围环境的动态演变和饮食结构的调整密切相关。目前,加味葛根芩连汤在不同饮食环境下治疗 UC 的有效性和机制尚不清楚。在这里,我们选择加味葛根芩连汤(PBM)的主要活性成分,构建合理有效的复方方案。我们采用“5%葡聚糖硫酸钠(DSS)”和“高温高湿+高糖高脂+酒精+5%DSS”分别在普通环境和岭南地区诱导 UC 大鼠模型,然后考察 PBM(89.96mg/kg 和 179.92mg/kg)对两种 UC 大鼠的治疗作用。通过肠道菌群消耗和粪便微生物群移植(FMT)实验,鉴定 PBM 抗 UC 作用中肠道微生物群的作用。随后,我们分别通过 16SrDNA 技术和靶向代谢组学监测 PBM 处理和 FMT 处理大鼠结肠中肠道微生物群和粪便代谢物的变化。PBM 处理和 FMT 处理大鼠的结肠炎症均明显缓解,表现为体重减轻、血性粪便、腹泻、疾病活动指数(DAI)评分、结肠长度缩短以及结肠组织学损伤减少。有趣的是,肠道菌群的消耗带走了 PBM 的保护作用,证实了肠道菌群在 PBM 抗 UC 作用中的重要性。然后我们的研究结果表明,PBM 不仅可以通过增加 Akkermansia 和 Romboutsia 来调节肠道微生物群,还可以减少 Escherichia-Shigella。更重要的是,PBM 可以增加结肠炎大鼠中丙酸和总短链脂肪酸(SCFAs)的产生,调节中长链脂肪酸(M-LCFAs),维持胆汁酸(BAs)稳态,调节氨基酸(AA)代谢。肠道环境的转化可能与 colonic 黏膜中抗炎、抗氧化和紧密连接蛋白表达的上调有关。综上所述,PBM 通过肠道微生物群依赖性显示出抗 UC 活性的潜力,有望成为一种补充和替代医学的草药疗法。
Pathogens. 2025-7-4